Great West Life Assurance CO Regenxbio Inc. Transaction History

Great West Life Assurance CO

$49.6 Billion
Q1 2024

A detailed history of Great West Life Assurance CO transactions in Regenxbio Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 37,211 shares of RGNX stock, worth $405,599. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,211

Previous 33,135 12.3%

Holding current value

$405,599

Previous $593,000 32.04%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$12.17 - $24.61 $49,604 - $100,310	4,076 Added 12.3%	37,211 $783,000
Q4 2023 Feb 13, 2024	SELL	$12.89 - $20.82 $264,425 - $427,101	-20,514 Reduced 38.24%	33,135 $593,000
Q3 2023 Nov 14, 2023	BUY	$16.46 - $19.99 $107,516 - $130,574	6,532 Added 13.86%	53,649 $883,000
Q2 2023 Aug 10, 2023	SELL	$17.23 - $21.71 $75,553 - $95,198	-4,385 Reduced 8.51%	47,117 $942,000
Q1 2023 May 12, 2023	SELL	$18.08 - $24.55 $46,085 - $62,577	-2,549 Reduced 4.72%	51,502 $974,000

Q4 2022 Feb 10, 2023	BUY	$20.4 - $24.73 $80,478 - $97,559	3,945 Added 7.87%	54,051 $1.23 Million
Q3 2022 Nov 01, 2022	BUY	$22.29 - $35.04 $1.12 Million - $1.76 Million	50,106 New	50,106 $1.33 Million
Q2 2022 Aug 09, 2022	BUY	$19.35 - $35.04 $93,228 - $168,822	4,818 Added 15.06%	36,804 $909,000
Q1 2022 May 12, 2022	SELL	$24.62 - $34.31 $13,541 - $18,870	-550 Reduced 1.69%	31,986 $1.09 Million
Q4 2021 Feb 14, 2022	BUY	$30.19 - $40.28 $8,211 - $10,956	272 Added 0.84%	32,536 $1.06 Million
Q3 2021 Nov 15, 2021	BUY	$29.09 - $45.68 $56,725 - $89,076	1,950 Added 6.43%	32,264 $1.36 Million
Q2 2021 Aug 11, 2021	SELL	$32.46 - $40.48 $1,882 - $2,347	-58 Reduced 0.19%	30,314 $1.18 Million
Q1 2021 May 17, 2021	BUY	$33.61 - $49.95 $31,223 - $46,403	929 Added 3.16%	30,372 $1.04 Million
Q4 2020 Feb 16, 2021	SELL	$26.52 - $49.35 $102,605 - $190,935	-3,869 Reduced 11.61%	29,443 $1.34 Million
Q3 2020 Nov 13, 2020	SELL	$27.01 - $40.26 $142,639 - $212,613	-5,281 Reduced 13.68%	33,312 $916,000
Q2 2020 Aug 17, 2020	SELL	$27.75 - $43.44 $40,487 - $63,378	-1,459 Reduced 3.64%	38,593 $1.42 Million
Q1 2020 May 14, 2020	BUY	$21.5 - $54.2 $51,471 - $129,754	2,394 Added 6.36%	40,052 $1.29 Million
Q4 2019 Feb 11, 2020	BUY	$34.54 - $44.87 $1.3 Million - $1.69 Million	37,658 New	37,658 $1.54 Million
Q3 2019 Oct 25, 2019	SELL	$31.84 - $50.88 $1.28 Million - $2.04 Million	-40,117 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$42.0 - $59.29 $62,874 - $88,757	-1,497 Reduced 3.6%	40,117 $0
Q1 2019 May 08, 2019	BUY	$40.82 - $62.45 $116,949 - $178,919	2,865 Added 7.39%	41,614 $2.38 Million
Q4 2018 Feb 12, 2019	BUY	$39.11 - $75.15 $55,536 - $106,713	1,420 Added 3.8%	38,749 $1.5 Million
Q3 2018 Nov 13, 2018	BUY	$65.0 - $82.15 $109,135 - $137,929	1,679 Added 4.71%	37,329 $2.81 Million
Q2 2018 Aug 10, 2018	BUY	$27.2 - $74.35 $909,840 - $2.49 Million	33,450 Added 1520.45%	35,650 $2.56 Million
Q3 2017 Nov 09, 2017	BUY	$18.0 - $32.95 $39,600 - $72,490	2,200	2,200 $70,000

Others Institutions Holding RGNX

# of Institutions

193

Shares Held

42.1M

Call Options Held

80.6K

Put Options Held

55.2K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $471M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Regenxbio Inc. Transaction History